Angiodynamics, Inc.
Clinical trials sponsored by Angiodynamics, Inc., explained in plain language.
-
New clot-sucking device aims to save lungs and lives
Disease control Recruiting nowThis study tests a device that suctions blood clots out of the lungs in people with a severe type of pulmonary embolism (a blockage in the lung artery). About 256 adults with symptoms for up to 14 days will be enrolled. The goal is to see if the procedure safely reduces clot burd…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 17, 2026 08:01 UTC
-
New device aims to save legs from amputation in blocked artery trial
Disease control Recruiting nowThis study tests whether a special device called the Auryon Atherectomy System, used with standard balloon angioplasty, is better than balloon angioplasty alone for treating blocked arteries below the knee in people with critical limb ischemia. About 224 adults with severe leg pa…
Phase: PHASE4 • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New device aims to safely suck out deadly lung clots and recycle your own blood
Disease control Recruiting nowThis study tests a medical device that removes blood clots from the lungs of people with a serious type of pulmonary embolism. The device also cleans and returns the patient's own blood to their body. About 39 adults with acute intermediate-risk pulmonary embolism will be enrolle…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 12, 2026 13:41 UTC